| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/23/2006 | US7049403 Insulin/IGF/relaxin family polypeptides and DNAS thereof |
| 05/23/2006 | US7049345 Fat-binding polymers |
| 05/23/2006 | US7049344 arylguanidine derivatives, for example N-[4-(2,3-bis-Bocguanidino)benzyl]2-(benzyl-oxycarbonyl)-2-phenylaceataride, N-(4-guanidinobenzyl) 2-(benzyloxycarbonyl)-2-phenylacetamide hydrochloride; antimetastasis agents |
| 05/23/2006 | US7049343 Nitrogen compounds such as 3-(N'-(2,6-dinitro-4-trifluoro methylphenyl)-N-(3-methoxyphenylhydrazino)propionic acid, used as glycine transport antagonists for prophylaxis of psychological disorders |
| 05/23/2006 | US7049342 Substituted phenylpropionic acid derivatives |
| 05/23/2006 | US7049341 Antidiabetic agents |
| 05/23/2006 | US7049340 administering ramipril, ramiprilat or other ramiprilat derivative; for improving visual acuity and visual field in normal subjects, as well as for treating ophthalmologic pathologies involving vascular factor, in particular glaucomatous neuropathy, degenerative choriopathy of strong myopia |
| 05/23/2006 | US7049339 comprises zinc sulphate, copper sulphate, an organic acid, an alkali metal salt; more effective at applying an active ingredient to a hoof than a conventional, non-colloid system; treatment of digital dermatitis |
| 05/23/2006 | US7049338 Antiproliferative agents |
| 05/23/2006 | US7049337 Treating schizophrenia, Parkinson's disease, and cocaine addiction; Central Nervous System (CNS); ring systems substituted with an alkynylamino group; for example, 2-(N-propyn-3-yl-N-(2-cyanoethyl)amino)naphth-7-ol |
| 05/23/2006 | US7049336 Method for diagnosing neuronal diseases and for treating primary hemostasis deficiency |
| 05/23/2006 | US7049335 3-azabicyclo[3.1.0]hexane derivatives |
| 05/23/2006 | US7049334 Enhancement of learning and memory and treatment of amnesia |
| 05/23/2006 | US7049333 Substituted thiophenes: compositions, processes of making, and uses in disease treatment and diagnosis |
| 05/23/2006 | US7049332 Effective against mutations; such as 2,3-Dihydro-4-ethyl-1-(3-methylphenylamino)-5-phenyl-1H-imidazole-2-thione |
| 05/23/2006 | US7049331 1,2,4-thiadiazole derivatives as melanocortin receptor modulators |
| 05/23/2006 | US7049330 Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents |
| 05/23/2006 | US7049329 Phenylalkylene-substituted or allyloxyphenylmethyl-substituted, e.g., N-(p-allyloxybenzyl-N-(2-methoxyethyl)-N-(3-phenylallyl)amine; endocannabinoid agonists |
| 05/23/2006 | US7049328 Use for deferiprone |
| 05/23/2006 | US7049327 For therapy of pain |
| 05/23/2006 | US7049326 Altering a drug's distribution, metabolism and elimination properties, especially by modifying with aralkyl ester moieties to increase rate of metabolism to inactive and nontoxic metabolites when exposure is halted; surgery, riots |
| 05/23/2006 | US7049325 Quinoline derivatives as anti-inflammatory agents |
| 05/23/2006 | US7049324 antitumor agents |
| 05/23/2006 | US7049323 Amidoheterocycles as modulators of the melanocortin-4 receptor |
| 05/23/2006 | US7049322 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor |
| 05/23/2006 | US7049321 Methods and pharmaceutical compositions for treatment of central and peripheral nervous system disorders and compounds useful therefor |
| 05/23/2006 | US7049320 Drugs for treating physiological disorder, respiratory disorders, inflammatory disease, skin disorder, and antidepressants, treating bipolar disorder, drug abuse, drug dependence, gastrointestinal disorder, atherosclerosis |
| 05/23/2006 | US7049319 Colon cleansing composition and method |
| 05/23/2006 | US7049318 1-Benzyl-2-(5-benzylamino-1-methyl-6-oxo-4-pyridin-4-yl-1,6-dihydro-pyrimidin-2-ylamino)-ethyl]-(S)-carbamic acid tert-butyl ester or derivatives |
| 05/23/2006 | US7049317 CCR-3 receptor antagonists |
| 05/23/2006 | US7049316 Prodrugs of CC-1065 analogs |
| 05/23/2006 | US7049315 Solubilized topoisomerase poisons |
| 05/23/2006 | US7049314 Cyclopentyl indole derivatives |
| 05/23/2006 | US7049313 Induce immunology response; anticancer agents |
| 05/23/2006 | US7049312 2H-1,4-benzothiazin-3(4H)-one derivative as anticarcinogenic and antiproliferative agent; inhibitors of serine/threonine and tyrosine kinase activity |
| 05/23/2006 | US7049311 Pyrrolbenzodiazepines |
| 05/23/2006 | US7049310 Therapy for bacteria infections |
| 05/23/2006 | US7049309 Administering a therapeutically effective amount of 3-thia-4-(2-oxy/hydroxyphenyl)quinolin-2-one derivative to a patient to treat erectile dysfunction or irritable bowel syndrome |
| 05/23/2006 | US7049308 For therapy of inflammatory or painful disorder |
| 05/23/2006 | US7049307 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor |
| 05/23/2006 | US7049306 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4. |
| 05/23/2006 | US7049305 Bile-acid conjugates providing for sustained systemic concentration of drugs |
| 05/23/2006 | US7049304 Aryl boronic acids for treating obesity |
| 05/23/2006 | US7049303 Inhibition of viruses |
| 05/23/2006 | US7049301 Quercetin derivatives and their medical usages |
| 05/23/2006 | US7049300 C-glycoside compounds for stimulating the synthesis of glycosaminoglycans |
| 05/23/2006 | US7049299 Preparing toothpaste comprising a sorbitol syrup as main humectant, at least an abrasive (silicas, calcium phosphate, caslium carbonate etc.) and a gelling agent; sorbitol syrup humectant with dry matter content from 73-82.9 % |
| 05/23/2006 | US7049297 Indazole peptidomimetics as thrombin receptor antagonists |
| 05/23/2006 | US7049293 Peptide and osteogenetic accelerator |
| 05/23/2006 | US7049288 Administering to a host for inhibiting absorption of dietary starch, an effective amount of a phaseolamin and vanadium (vanadium bound by a glycoprotein matrix which is produced by Lactobacillus acidophilus and Saccharomyces cervisiae) |
| 05/23/2006 | US7049286 Insulin conjugates and methods of use thereof |
| 05/23/2006 | US7049134 Contains a rep gene open reading frame from a geminiviridae, circoviridae or genus nanovirus |
| 05/23/2006 | US7049124 Hyaluronidase from the Hirudinaria manillensis isolation, purification and recombinant method of production |
| 05/23/2006 | US7049084 Neuroblastoma cell lines expressing the α2δ subunit of calcium channels and methods therefore |
| 05/23/2006 | US7049078 Apolipoprotein E polymorphism and treatment of alzheimer's disease |
| 05/23/2006 | US7049059 Method of determining a chemotherapeutic regimen based on ERCC1 and TS expression |
| 05/23/2006 | US7049058 Methods for suppressing the induction of nitric oxide synthase in a cell |
| 05/23/2006 | US7048952 Formulation for inhibiting fungal and microbial growth comprising morinda citrifolia puree juice |
| 05/23/2006 | US7048950 Use of Emu Oil and its various fractions as a carrier for antifungal, antibacterial, and antiviral medications and preparations |
| 05/23/2006 | US7048948 Stable granulates containing S-adenosylmethionine and process for the preparation thereof |
| 05/23/2006 | US7048946 Formulation for controlled release of drugs by combining hyrophilic and hydrophobic agents |
| 05/23/2006 | US7048945 Timed pulsatile drug delivery systems |
| 05/23/2006 | US7048943 Carotenoid-loaded liposomes |
| 05/23/2006 | US7048940 alpha-pyrones in non-alcoholic beer, non-alcoholic wine and non-alcoholic distilled spirits as an effective carrier for the anticraving agents |
| 05/23/2006 | US7048939 Methods for the inhibition of neointima formation |
| 05/23/2006 | US7048937 Methods and compositions for control of coccidiosis |
| 05/23/2006 | US7048933 Mixing shoots of Pinaceae plants with water and saccharides followed by spontaneous fermenting with yeasts to form remedies for allergic diseases; side effect reduction; for treatment of asthma, atopic dermatitis |
| 05/23/2006 | US7048932 Preparation and standardization of immunomodulatory peptide-linked glucans with verifiable oral absorbability from coriolus versicolor |
| 05/23/2006 | US7048928 Inhibitor of histamine synthesis, especially of of histidine decarboxylase such as tritoqualine; allergen, e.g., cysteine protease |
| 05/23/2006 | US7048926 Methods of agonizing and antagonizing FabK |
| 05/23/2006 | US7048924 Combination antiviral and interleukin-2 therapy for HIV infection |
| 05/23/2006 | US7048920 A replication-competent adenovirus vector comprising an adenovirus gene essential for replication; use as antitumor agent |
| 05/23/2006 | US7048917 Fat-binding polymers |
| 05/23/2006 | US7048914 Placental alkaline phosphatase to control diabetes |
| 05/23/2006 | US7048909 Aerosols containing nondegraded atenolol, pindolol, esmolol, propranolol, or metoprolol |
| 05/23/2006 | US7048908 Particles for inhalation having sustained release properties |
| 05/23/2006 | US7048906 Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
| 05/23/2006 | CA2428870C Freeze-dried pantoprazole preparation and pantoprazole injection |
| 05/23/2006 | CA2411766C Non-nucleoside reverse transcriptase inhibitors |
| 05/23/2006 | CA2339630C Carboline derivatives as cgmp phosphodiesterase inhibitors |
| 05/23/2006 | CA2312729C Use of 9-deoxy-2', 9-.alpha.-methano-3- oxa-4,5,6- trinor-3, 7-(1',3'-interphenylene) -13,14-dihydro- prostaglandin f1 to treat peripheral vascular disease |
| 05/23/2006 | CA2301189C Non-steroidal ligands for the estrogen receptor |
| 05/23/2006 | CA2299405C Method for the continuous production of hydrolytically broken down and possibly substituted starch, use of hydrolytically broken down starch and device for producing same |
| 05/23/2006 | CA2291134C Method for the preparation of citalopram |
| 05/23/2006 | CA2263921C Oral delayed immediate release formulation and method of preparation therefor |
| 05/23/2006 | CA2261619C Nucleotide analogs |
| 05/23/2006 | CA2259550C Cosmetic or dermatological compound containing at least one natural, recombinant or analogous arachnid silk protein |
| 05/23/2006 | CA2257200C Substituted imidazoles having cytokine inhibitory activity |
| 05/23/2006 | CA2245206C Use of an inhibitor of excitatory amino acids in a cosmetic or dermatological compound for sensitive skin, and the compound thus obtained |
| 05/23/2006 | CA2242494C Novel n-substituted 4-((4'-aminobenzoyl)-oxymethyl)-piperidines having gastric prokinetic properties |
| 05/23/2006 | CA2232141C Substituted tetracyclic tetrahydrofuran derivatives |
| 05/23/2006 | CA2227792C Polymeric drug formulations |
| 05/23/2006 | CA2222724C 3(2h)-pyridazinone derivatives and pharmaceutical compositions containing these compounds |
| 05/23/2006 | CA2201865C Laminin chains: diagnostic and therapeutic use |
| 05/23/2006 | CA2189140C New antagonist compounds |
| 05/23/2006 | CA2188841C Use of 2-amino-4-(4-fluorobenzylamino)-1-ethoxy-carbonylaminobenzene for the prophylaxis and treatment of the sequelae of acute and chronic reduced cerebral blood supply and neurodegenerative disorders |
| 05/23/2006 | CA2173747C Calcium receptor-active arylalkyl amines |
| 05/23/2006 | CA2164863C Polyphenol derivative compositions and preparation thereof |
| 05/23/2006 | CA2159627C Novel prednisolone derivatives |
| 05/23/2006 | CA2158454C Taxanes having furyl or thienyl substituted side-chain |